Concepedia

Are all 5-HT3 receptor antagonists the same?

Paul Andrews, Pritiranjan Bhandari, Philip T. Davey, Sharon Bingham, Helen E. Marr, Peter R. Blower

European Journal of Cancer · 1992 · 133 citations · 9 references

DOI

Concepts

References

9

Pharmacological properties of GR38032F, a novel antagonist at 5‐HT<sub>3</sub> receptors

A. Butler, Julia M. Hill, S.J. Ireland et al. · British Journal of Pharmacology · 1988 · 379 citations · Full text

, , +14

Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism

Wesley D. Miner, Gareth J. Sanger · British Journal of Pharmacology · 1986 · 338 citations · Full text

, , +9

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694

J. Bermúdez, E A Boyle, WD Miner · British Journal of Cancer · 1988 · 214 citations · Full text

, , +10

Cisplatin-induced emesis in the Ferret: a new animal model.

A P Florczyk, John E. Schurig, William T. Bradner · PubMed · 1982 · 102 citations

, , +14

Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.

Steven M. Grunberg, Lani L. Stevenson, Christy Russell et al. · Journal of Clinical Oncology · 1989 · 102 citations

, , +17